VectorBuilder at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
VectorBuilder brings 3 presentations to ESGCT 2026 in Hamburg. Its contributions cover vector design and non-viral cell engineering, including a miniaturised plasmid and electroporation workflow for primary human T cells. Other work retargets AAV for eye therapies and splits large or complex genes across two AAV vectors.
| Organization | ESGCT 2026 Attendance |
|---|---|
◇Silver Sponsor | |
Designs and makes custom vectors, virus packaging, libraries and stable cell lines, plus AAV capsid evolution and GMP plasmid and viral vector manufacturing. | Poster Wed Oct 28 1:30pm–3:30pm An integrated miniaturized plasmid and electroporation workflow for improved non-viral engineering of primary human T cells Poster Wed Oct 28 1:30pm–3:30pm Enhancing AAV targeting for next-generation ocular therapies Poster Thu Oct 29 2:00pm–4:00pm A novel modular split AAV vector system for efficient delivery of large and complex genes |
Instantly find 20 buyers from VectorBuilder
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction